Increased serum levels of microvesicles in nonvalvular atrial fibrillation determinated by ELISA using a specific monoclonal antibody AD-1

Clinica Chimica Acta

Volumn 411, Issue 21-22, 2010, Pages 1700-1704

  Wang, Hua ^a   Yan, Hui min ^a   Tang, Meng xiong ^a   Wang, Zhi hao ^a   Zhong, Ming ^a   Zhang, Yun ^a   Deng, Jing ti ^b   Zhang, Wei ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Inflammation; Microvesicles; Platelet activation

Indexed keywords

CYTOSOL AMINOPEPTIDASE; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; PADGEM PROTEIN;

AGED; ANTIBODY AFFINITY; ARTICLE; BODY WEIGHT; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEMBRANE VESICLE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; THROMBOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MALE; METHODS; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION;

EID: 77956491594     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.07.005     Document Type: Article

References (32)

1. Wattigney W.A., Mensah G.A., Croft J.B. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 2003, 108(6):711-716.
2. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987, 147(9):1561-1564.
3. Pongratz G., et al. Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation. Chest 1997, 111(4):929-933.
4. Choudhury A., et al. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention. Chest 2008, 134(3):574-581.
5. Boos C.J., Anderson R.A., Lip G.Y. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 2006, 27(2):136-149.
6. Oleksowicz L., et al. Morphologic and ultrastructural evidence of interleukin-6 induced platelet activation. Am J Hematol 1995, 48(2):92-99.
7. von Zur Muhlen C., et al. A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI. J Clin Invest 2008, 118(3):1198-1207.
8. Lou J., et al. Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Am J Pathol 1997, 151(5):1397-1405.
9. Heijnen H.F., et al. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999, 94(11):3791-3799.
10. Admyre C., et al. Exosomes - nanovesicles with possible roles in allergic inflammation. Allergy 2008, 63(4):404-408.
11. Andrews R.K., Berndt M.C. Platelet physiology and thrombosis. Thromb Res 2004, 114(5-6):447-453.
12. Cocucci E., Racchetti G., Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19(2):43-51.
13. Ardoin S.P., Shanahan J.C., Pisetsky D.S. The role of microparticles in inflammation and thrombosis. Scand J Immunol 2007, 66(2-3):159-165.
14. Deng J.T., et al. Purification of circulating liver plasma membrane fragments using a monoclonal antileucine aminopeptidase antibody. Hepatology 1996, 23(3):445-454.
15. Deng J.T., Parsons P.G. Solid phase immunoassay for high molecular weight alkaline phosphatase in human sera using a specific monoclonal antibody. Clin Chim Acta 1988, 176(3):291-301.
16. Janiszewski M., et al. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: a novel vascular redox pathway. Crit Care Med 2004, 32(3):818-825.
17. Aharon A., Tamari T., Brenner B. Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells. Thromb Haemost 2008, 100(5):878-885.
18. Andre F., et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002, 360(9329):295-305.
19. Azevedo L.C., Pedro M.A., Laurindo F.R. Circulating microparticles as therapeutic targets in cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2007, 2(1):41-51.
20. Deng Z.B., et al. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 2009, 58(11):2498-2505.
21. Jy W., et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004, 2(10):1842-1851.
22. Osumi K., et al. Development and assessment of enzyme immunoassay for platelet-derived microparticles. Thromb Haemost 2001, 85(2):326-330.
23. Deng J.T., et al. Differential release of human intestinal alkaline phosphatase in duodenal fluid and serum. Clin Chem 1992, 38(12):2532-2538.
24. Van Hoof V.O., Deng J.T., De Broe M.E. How do plasma membranes reach the circulation?. Clin Chim Acta 1997, 266(1):23-31.
25. Menashi S., Weintroub H., Crawford N. Characterization of human platelet surface and intracellular membranes isolated by free flow electrophoresis. J Biol Chem 1981, 256(8):4095-4101.
26. Potolicchio I., et al. Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol 2005, 175(4):2237-2243.
27. Ogawa Y., et al. Exosome-like vesicles in Gloydius blomhoffii blomhoffii venom. Toxicon 2008, 51(6):984-993.
28. Simpson R.J., et al. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 2009, 6(3):267-283.
29. Araki S., et al. Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patients. Diab Care 2009, 32(11):2062-2067.
30. Cleanthis M., et al. Soluble but not platelet P-selectin correlates with spontaneous platelet aggregation: a pilot study. Clin Appl Thromb Hemost 2008, 14(2):227-233.
31. Minamino T., et al. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide. Circulation 1998, 98(17):1721-1727.
32. Choudhury A., et al. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy. Chest 2007, 131(3):809-815.